The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells

Aim. To perform the comparative study both of qualitative and quantitative content of lipids in parental and drug resistant breast cancer cells. Materials and methods. Parental (MCF-7/S) and resistant to cisplatin (MCF-7/CP) and doxorubicin (MCF-7/Dox) human breast cancer cells were used in the stud...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2012
Автори: Todor, I.N., Lukianova, N.Yu., Chekhun, V.F.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2012
Назва видання:Experimental Oncology
Теми:
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/138697
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells / I.N. Todor, N.Yu. Lukianova, V.F. Chekhun // Experimental Oncology. — 2012. — Т. 34, № 2. — С. 97-100. — Бібліогр.: 28 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id irk-123456789-138697
record_format dspace
spelling irk-123456789-1386972018-06-20T03:08:16Z The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells Todor, I.N. Lukianova, N.Yu. Chekhun, V.F. Original contributions Aim. To perform the comparative study both of qualitative and quantitative content of lipids in parental and drug resistant breast cancer cells. Materials and methods. Parental (MCF-7/S) and resistant to cisplatin (MCF-7/CP) and doxorubicin (MCF-7/Dox) human breast cancer cells were used in the study. Cholesterol, total lipids and phospholipids content were determined by means of thin-layer chromatography. Results. It was found that cholesterol as well as cholesterol ethers content are significantly higher but diacylglycerols, triacyl­glycerols content are significantly lower in resistant cell strains than in parental (sensitive) cells. Moreover the analysis of individual phospholipids showed the increase of sphingomyelin, phosphatidylserine, cardiolipin, phosphatidic acid and the decrease of phosphatidy­lethanolamine, phosphatidylcholine in MCF-7/CP and MCF-7/Dox cells. Conclusion. Obtained results allow to suggest that the lipid profile changes can mediate the modulation of membrane fluidity in drug resistant MCF-7 breast cancer cells. 2012 Article The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells / I.N. Todor, N.Yu. Lukianova, V.F. Chekhun // Experimental Oncology. — 2012. — Т. 34, № 2. — С. 97-100. — Бібліогр.: 28 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/138697 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Original contributions
Original contributions
spellingShingle Original contributions
Original contributions
Todor, I.N.
Lukianova, N.Yu.
Chekhun, V.F.
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
Experimental Oncology
description Aim. To perform the comparative study both of qualitative and quantitative content of lipids in parental and drug resistant breast cancer cells. Materials and methods. Parental (MCF-7/S) and resistant to cisplatin (MCF-7/CP) and doxorubicin (MCF-7/Dox) human breast cancer cells were used in the study. Cholesterol, total lipids and phospholipids content were determined by means of thin-layer chromatography. Results. It was found that cholesterol as well as cholesterol ethers content are significantly higher but diacylglycerols, triacyl­glycerols content are significantly lower in resistant cell strains than in parental (sensitive) cells. Moreover the analysis of individual phospholipids showed the increase of sphingomyelin, phosphatidylserine, cardiolipin, phosphatidic acid and the decrease of phosphatidy­lethanolamine, phosphatidylcholine in MCF-7/CP and MCF-7/Dox cells. Conclusion. Obtained results allow to suggest that the lipid profile changes can mediate the modulation of membrane fluidity in drug resistant MCF-7 breast cancer cells.
format Article
author Todor, I.N.
Lukianova, N.Yu.
Chekhun, V.F.
author_facet Todor, I.N.
Lukianova, N.Yu.
Chekhun, V.F.
author_sort Todor, I.N.
title The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
title_short The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
title_full The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
title_fullStr The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
title_full_unstemmed The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
title_sort lipid content of cisplatin- and doxorubicin-resistant mcf-7 human breast cancer cells
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2012
topic_facet Original contributions
url http://dspace.nbuv.gov.ua/handle/123456789/138697
citation_txt The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells / I.N. Todor, N.Yu. Lukianova, V.F. Chekhun // Experimental Oncology. — 2012. — Т. 34, № 2. — С. 97-100. — Бібліогр.: 28 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT todorin thelipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
AT lukianovanyu thelipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
AT chekhunvf thelipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
AT todorin lipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
AT lukianovanyu lipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
AT chekhunvf lipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
first_indexed 2023-10-18T21:19:16Z
last_indexed 2023-10-18T21:19:16Z
_version_ 1796152501118959616